
ACC Q4 FY26 Earnings Preview: Cement Sector Expectations
Updated: 9 Mar 2026 • 5:33 pm
Posted by:

ACC Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. ACC was listed on the National Stock Exchange (NSE) on 20-Nov-1996. ACC share has its face value of 10 per share, and its NSE symbol is ACC. The company operates in the Materials sector and primarily belongs to the Cement industry.
ACC Q4 Results 2026 Preview
- ACC Q4 FY26 revenue is expected to be around Moderate Growth Expected, representing a 10-13% YoY increase compared to the same quarter last year.
- Profit After Tax, or PAT, is projected to rise 11-15% YoY.
- EBITDA to rise 12%.
- ACC is expected to show Moderate Growth Expected in its revenue.
Click and Sign Up to Get Live Updates on Q4 Results
ACC Share Performance
- Over the past six months, ACC share price has 18% by 10-14% to 1,448.30.
- Moreover, over the past year, the stock has 31% by Up
- Despite this weak short-term performance, ACC stock has delivered a financially sound 165% return over the past 5 years.
- As of today, 09-03-2026, the ACC share price is trading at 1,448.30 per share.
Key Factors to Watch for ACC Q4 Results FY26
- Revenue Growth & Segment Performance – Focus on topline growth in the Cement industry within the Materials sector.
- Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
- Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
- Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
- Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.
About ACC
ACC is a major Indian manufacturer of cement and ready-mix concrete, catering to infrastructure, residential, and commercial construction markets. It is recognized for its broad product portfolio, extensive distribution network, and commitment to sustainable construction solutions.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Final Thoughts
ACC is gear up to announce its Q4 FY26 results. Analysts expect 10-13% revenue growth, a 11-15% rise in PAT, and a 12% rise in EBITDA. ACC focuses on revenue growth from order execution, margin improvement, a strong order book, and management.
Stay informed with Univest blogs to get real-time updates on ACC Q4 results FY26.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Aakash Exploration Services Gears Up for Q4 Reveal. Check Key Expectations Here
Aarey Drugs & Pharmaceuticals Gears Up for Q4 Reveal. Check Key Expectations Here
Aarnav Fashions Gears Up for Q4 Reveal. Check Key Expectations Here
Aaron Industries Gears Up for Q4 Reveal. Check Key Expectations Here
ABB India Q4 FY26 Results: Analysts Expect Industrial Growth
Recent Articles

LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
15 May 2026

Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
15 May 2026

Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
15 May 2026

Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
15 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
Tata Motors Passenger Vehicles Q4 FY26 Results: PAT of Rs 2,406 (standalone Tata Motors) crore (up 69.55% Yo Passenger Vehicles and EV
Popular this week
LT Foods Q4 FY26 Results: PAT of Rs 135.67 crore Basmati Rice and Food Products
Muthoot Finance Q4 FY26 Results: PAT of Rs 10,607 (FY26 consolidated annual) crore (up 98% Yo Gold Loan NBFC
Alivus Life Sciences Q4 FY26 Results: Announced May 14 2026 Pharma API and CDMO – Formerly Glenmark Life Sciences
Chalet Hotels Q4 FY26 Results: Announced May 14 2026 Luxury and Business Hotels
Tata Motors Passenger Vehicles Q4 FY26 Results: PAT of Rs 2,406 (standalone Tata Motors) crore (up 69.55% Yo Passenger Vehicles and EV

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





